Murray JS - Search Results

1

Chan-Tack KM, Murray JS, Birnkrant DB. Chan-Tack KM, et al. Among authors: murray js. N Engl J Med. 2009 Oct 22;361(17):1713-4. doi: 10.1056/NEJMc0905290. N Engl J Med. 2009. PMID: 19846864 No abstract available.

2

Antiviral therapy and outcomes in hospitalized patients with influenza.

Chan-Tack KM, Murray JS. Chan-Tack KM, et al. Among authors: murray js. Clin Infect Dis. 2008 May 15;46(10):1628-9; author reply 1629-30. doi: 10.1086/587751. Clin Infect Dis. 2008. PMID: 18419504 No abstract available.

3

Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.

Riner A, Chan-Tack KM, Murray JS. Riner A, et al. Among authors: murray js. Postgrad Med. 2009 May;121(3):139-46. doi: 10.3810/pgm.2009.05.2014. Postgrad Med. 2009. PMID: 19491552 Review.

4

Gender Parity in Clinical PrEP Trials.

Murray J, Birnkrant D. Murray J, et al. N Engl J Med. 2019 Dec 26;381(26):2584-2585. doi: 10.1056/NEJMc1915473. N Engl J Med. 2019. PMID: 31881149 No abstract available.

5

HIV clinical trial design for antiretroviral development: moving forward.

Chan-Tack KM, Struble KA, Morgensztejn N, Murray JS, Gulick R, Cheng B, Weller I, Miller V. Chan-Tack KM, et al. Among authors: murray js. AIDS. 2008 Nov 30;22(18):2419-27. doi: 10.1097/QAD.0b013e32831692e6. AIDS. 2008. PMID: 19005265 Review. No abstract available.

6

Running a tightrope: regulatory challenges in the development of antiretrovirals.

Naeger LK, Struble KA, Murray JS, Birnkrant DB. Naeger LK, et al. Among authors: murray js. Antiviral Res. 2010 Jan;85(1):232-40. doi: 10.1016/j.antiviral.2009.07.016. Epub 2009 Aug 7. Antiviral Res. 2010. PMID: 19665489 Review.

7

Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).

Soon GG, Min M, Struble KA, Chan-Tack KM, Hammerstrom T, Qi K, Zhou S, Bhore R, Murray JS, Birnkrant DB. Soon GG, et al. Among authors: murray js. AIDS Patient Care STDS. 2012 Aug;26(8):444-53. doi: 10.1089/apc.2011.0278. Epub 2012 Jun 26. AIDS Patient Care STDS. 2012. PMID: 22734949

8

FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.

Mishra P, Florian J, Qi K, Zeng W, Naeger LK, Donaldson E, Connelly S, O'Rear J, Price D, Murray J, Birnkrant D. Mishra P, et al. Gastroenterology. 2014 Dec;147(6):1196-200. doi: 10.1053/j.gastro.2014.10.027. Epub 2014 Oct 27. Gastroenterology. 2014. PMID: 25449024 No abstract available.

9

Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs.

Mishra P, Murray J, Birnkrant D. Mishra P, et al. Hepatology. 2015 Oct;62(4):1298-303. doi: 10.1002/hep.27880. Epub 2015 Jun 19. Hepatology. 2015. PMID: 25953139

10

HCV genotype 4, 5 and 6: Distribution of viral subtypes and sustained virologic response rates in clinical trials of approved direct-acting antiviral regimens.

Boyd SD, Harrington P, Komatsu TE, Naeger LK, Chan-Tack K, Murray J, Birnkrant D, Struble K. Boyd SD, et al. J Viral Hepat. 2018 Aug;25(8):969-975. doi: 10.1111/jvh.12896. Epub 2018 May 8. J Viral Hepat. 2018. PMID: 29577495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page